Indication

Granuloma annulare

Granuloma annulare is a benign, non-infectious, chronic inflammatory dermatologic disorder of idiopathic etiology. Read more about Granuloma annulare

733 drugs 192 manufacturers

Advertisement

Drugs that treat it

Common Granuloma annulare therapies.

Showing 460–468 of 733 drugs

Filter & compare in the drug finder →Opens the drug finder with Granuloma annulare preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Granuloma annulare.

Granuloma annulare is a benign, non-infectious, chronic inflammatory dermatologic disorder of idiopathic etiology.

It can present across all age groups, with a higher prevalence observed in females, children, and young adults.

Clinically, it most often manifests as localized, asymptomatic, or mildly pruritic flesh-colored to erythematous papules and plaques arranged in an annular configuration with central clearing, predominantly affecting the distal extremities.

Other recognized clinical variants include generalized (disseminated), subcutaneous, patch, and perforating forms.

Histopathologically, the condition is characterized by foci of necrobiotic collagen degeneration surrounded by a palisading or interstitial lymphohistiocytic infiltrate with abundant dermal mucin deposition.

Personalize your experience

Follow Granuloma annulare and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it